The provincial and federal governments signed a four-year agreement last year to implement a national PharmaCare initiative in B.C. with $670 million in federal government funding.
American Society of Clinical Psychopharmacology Task Force identifies situations where discontinuation of certain psychotropic medications may be clinically indicated.